Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Zahn

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of the American Chemical Society|October 28, 2015
Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen BondAndreas Lange, Marcel Günther, Felix Michael Büttner, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Nature Medicine|July 9, 2002
Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cellsZoltan A Nagy, Bernd Hubner, Corinna Löhning, et al.
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of the American Chemical Society|October 28, 2015
Targeting the Gatekeeper MET146 of C-Jun N-Terminal Kinase 3 Induces a Bivalent Halogen/Chalcogen BondAndreas Lange, Marcel Günther, Felix Michael Büttner, et al.
Blood|June 26, 2009
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cellsFrancois Romagné, Pascale André, Pieter Spee, et al.
Nature Medicine|July 9, 2002
Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cellsZoltan A Nagy, Bernd Hubner, Corinna Löhning, et al.
Hepatology (Baltimore, Md.)|September 25, 2004
Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in ratsChristopher J Parsons, Blair U Bradford, Clark Q Pan, et al.
Atherosclerosis|October 31, 2020
A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?Günaj Rakipovski, Bidda Rolin, Natasha Barascuk, et al.
Pageof 7